| Financial Year |
March 31 2023 |
| Monetary Funds |
87,103,366.54 |
| Held-for-trading Financial Assets |
6,000,000.00 |
| Notes Receivable |
37,529,599.88 |
| Accounts Receivable |
114,271,075.12 |
| Advances to Suppliers |
10,013,843.92 |
| Other Receivables |
427,442.72 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
80,657,761.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
500,055.96 |
| Total Current Assets |
386,854,055.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
99,728,940.45 |
| Investment Properties |
-- |
| Fixed Assetes |
260,415,742.06 |
| Under-construction Projects |
7,862,184.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
68,290,879.90 |
| R&D expenses |
-- |
| Goodwill |
67,282,119.45 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
1,270,049.77 |
| Other Non-Current Assets |
5,751,576.85 |
| Sub-Total of Non-Current Assets |
515,102,804.10 |
| Total Assets |
901,956,859.56 |
| Short-Term Loans |
49,047,888.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
40,988,569.60 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,708,895.96 |
| Taxes Payable |
8,856,634.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,617,286.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,372,742.78 |
| Other Current Liabilities |
26,346,030.74 |
| Sub-Total of Current Liabilities |
152,545,168.03 |
| Long-term Loans |
76,092,888.89 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,106,576.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
88,844,324.18 |
| Total Liabilities |
241,389,492.21 |
| Paid-In Capital(Or Share Stock) |
70,000,000.00 |
| Capital Surplus |
351,405,928.25 |
| Surplus Reserve |
27,015,540.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
180,661,200.84 |
| Minority Stockholder's Interest |
31,484,697.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
629,082,669.86 |
| Owner's Equity（Stockholder's Equity） |
660,567,367.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
901,956,859.56 |
